TrialJournal of clinical immunology2014

Efficacy and safety of IgPro20, a subcutaneous immunoglobulin, in Japanese patients with primary immunodeficiency diseases.

Hirokazu Kanegane et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.